Hospice Enrollment and Central Nervous System-Active Medication Prescribing to Medicare Decedents with Dementia

Lauren B Gerlach; Lan Zhang; Joan Teno; Donovan T Maust

doi:10.1001/jamapsychiatry.2024.1866

Hospice Enrollment and Central Nervous System-Active Medication Prescribing to Medicare Decedents with Dementia

JAMA Psychiatry. 2024 Sep 1;81(9):944-946. doi: 10.1001/jamapsychiatry.2024.1866.

Authors

Lauren B Gerlach^{1

2}, Lan Zhang¹, Joan Teno³, Donovan T Maust^{1

2

4}

Affiliations

¹ Department of Psychiatry, University of Michigan Medical School, Ann Arbor.
² Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.
³ Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.
⁴ Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.

PMID: 39018032
PMCID: PMC11255969 (available on 2025-07-17)
DOI: 10.1001/jamapsychiatry.2024.1866

No abstract available

Plain language summary

This study explores the extent to which hospice enrollment is associated with CNS–active medication exposure among Medicare decedents with Alzheimer disease and related dementias.

MeSH terms

Aged
Aged, 80 and over
Central Nervous System Agents / therapeutic use
Dementia* / drug therapy
Drug Prescriptions / statistics & numerical data
Female
Hospice Care / statistics & numerical data
Humans
Male
Medicare* / statistics & numerical data
United States

Substances

Central Nervous System Agents